Skip to main content

Big pharma

I got a surprise package from Big Pharma today. Last week I filled my first US prescription for Tagrisso, so AstraZeneca sent me a "starter pack." 


If I didn't have insurance, a month's supply of Tagrisso would cost over $15,000. With Aetna, I'm paying $50. There's plenty to hate about Big Pharma (Exhibit A: Purdue Pharma and Sackler family), but I am thankful for scientific advances that have made targeted cancer therapy possible. I wish these therapies were available for everyone who needs them, not just the insured.  

Comments

  1. I wish too. I hate big pharma

    ReplyDelete
  2. But…but…!!! That would be SOCiALISM!!!! On my last trip to PA saw a bumper sticker on a car that said “I’ll fight socialism until hell freezes over. And then I’ll battle on the ice.” Uh huh. I hope you get to feeling better Esther and kick this thing quickly. We are pulling for you.

    ReplyDelete
    Replies
    1. Thanks, Kai! The cost of US healthcare is insane. :( My 2 weeks in Reston ICU cost $173K+. I've paid about $70 for various items.

      Delete

Post a Comment

Popular posts from this blog

Cancer- and Tagrisso-versaries

June 14 marked three years since my Stage IV lung cancer diagnosis and on June 30, I will complete three years on Tagrisso targeted therapy.  with my first Tagrisso pills (a sample from my oncologist), June 30, 2022 Every year as June approaches, I feel like I am reliving my own Stations of the Cross, recalling what happened each day as I walk toward the inevitable, gut-wrenching diagnosis: my GP telling me the x-ray showed “infiltration” and recommending a CT scan, getting the CT scan and the radiologist (and Leland) thinking I had TB, being sent to the LungenClinic, the doctor ruling out TB and telling me cancer was one of 3 possible explanations for my symptoms, but that it was "unlikely" because of my age, and so on. Not long ago, a Stage IV lung cancer diagnosis was a sure, quick death sentence. A researcher who wrote an article  commemorating the 20 th anniversary of the discovery the EGFR (epithelial growth factor receptor) mutation driving my cancer recalled that i...

Who needs their knees, anyway?

I hadn’t written a blog post about my knee injury because I wasn’t sure whether it was related to cancer, but now I know how they are connected. The short version is that my knee swelled up so badly that I couldn’t walk on the night of May 6th/morning of May 7 th.  Because I am on blood thinners, the knee joint kept filling up with blood, a condition that I learned is called hemarthrosis. I’ve spent the past 4+ weeks meeting with a bazillion doctors (GP, orthopedic doctor, orthopedic oncologist, orthopedic surgeon, hematologist), going to the ER (twice), having my knee drained (3 times), and mostly lying on the sofa for 2 of those weeks, trying to get the swelling to come down. I still have a bit of swelling, but I’ve been able to walk 10-20+ minutes the past week without making it worse. I’m still wearing a compression sleeve, which is a step up from the brace and crutches I was using before. Now for the longer version. There was no particular event that caused the injury. The d...

regular update

I had my regular oncology appointment in Pittsburgh yesterday. Dr. Villaruz said the scans look good and everything is stable. Although I don’t have much scanxiety nowadays, it’s always a relief to get good news. Just to be sure that my understanding was correct, I asked her why I’m not a candidate for surgery. It’s because of the cancer’s growth pattern. The one nodule that’s visible on the CT scan could just be scarring; she’s not sure if it’s a tumor. When I was diagnosed, I was told the lung cancer was “lepidic.” This means that the tumor cells were growing along the lining of the alveolar structures (air sacs).* That’s why my lungs looked like they were draped in cobwebs. You can’t do surgery in enough places to get all of it. Thankfully, Tagrisso swept out those cobwebs – and continues to do so. We go back in December for a regular appointment. *Lepidic spread tends to be slow-growing, with minimal invasion of nearby tissues, less chance of metastasis, and overall better progno...